Ortho VCs Are Getting Soft, But Still Show Spine

Private investors in orthopedic companies still are backing traditional and large joint companies, but soft tissue and biomaterials are drawing a solid total of early-stage capital.

This past month’s news of the monster private equity financings of Small Bone Innovations Inc. and ConforMIS Inc. drew a bright, white hot light on the state of venture investing in orthopedics start-ups. Does the $144 million committed to Small Bone Innovations, a mega start-up committed to the extremities (or small bone) sector, reflect broader investor interest in that increasingly interesting sector? [See Deal][See Deal] Likewise, what does $50 million put into in knee replacement company ConforMIS so far say about the entrepreneurial interest in the large but sleepy large joint sector? [See Deal] (See "SBI and ConforMIS Think and Act Globally In Search for Funds," this issue, for a detailed look at the two deals. Also see "SBI, ConforMIS Think and Act Globally in Search for Funds" - Medtech Insight, 1 July, 2009..)

A review of data in Elsevier’s Strategic Transactions database revealed that venture investors aren’t showing much interest in funding start-ups...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By 

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.

Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist

 

Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.

More from Business